Capsule of a kind of blood fat reducing the liver benefiting and preparation method thereof
Technical field
The present invention relates to the health food technology field of hepatoprotective and blood lipid regulation, especially relating to a kind of is the blood fat reducing liver-benefiting capsules and preparation method thereof of raw material with the Chinese medicine medicine.
Background technology
Along with China's rapid economic development, the raising of national life level, the adjustment of dietary structure, excessive consumption of alcohol and because in the food excessive albumen, lipid, saccharide to take in the disease and the potential hazard that bring more and more serious, as alcoholic liver, fatty liver, medicine liver etc.The patient of these diseases is more and more with relevant sub-health population, according to statistics, the pathogenesis of fatty liver rate has reached 10%, the alcoholic liver sickness rate has reached 1.92%, hyperlipidemia then is 3.84%, because chemical liver injury and hyperlipidemia to liver that factors such as ethanol, medicine, environmental pollution cause become a harm greatly that hinders people healthy.
Though the health food of some hepatoprotective and the medicine of some treatment hepatitis are also arranged at present, and these health foods and medicine exist many deficiencies.They are not strong to the health care of the chemical liver injury of liver, do not have the health care of blood lipid regulation exactly, and medicine and be not suitable for the situation that non-hepatitis is taken for a long time can not be applicable to for a long time and take.Disclosed a kind of medicine for the treatment of chronic hepatopathy of Chinese patent CN1243743 (2000) and preparation method thereof for example, it is a treatment hepatic fibrosis effect new Chinese medicine preferably, but owing to be medicine, constituent content wherein is not suitable for taking for a long time that people keep healthy and need.All these are difficult to satisfy the healthy health care needs of people.Exploitation in conjunction with the health food of hepatoprotective and two kinds of health cares of blood lipid regulation is very urgent.
Summary of the invention
The invention provides a kind of blood fat reducing liver-benefiting capsules and preparation method thereof.
The present invention is according to the theoretical health food that proposes of traditional Chinese medicine theory and health care, is to be raw materials of effective components with Ganoderma, Radix Salviae Miltiorrhizae, Fructus Lycii, Herb Gynostemmae Pentaphylli, Fructus Ligustri Lucidi, Rhizoma Alismatis, Tremella.
Blood fat reducing liver-benefiting capsules component of the present invention and weight portion content thereof are as follows:
Ganoderma 17.64~26.46g, Radix Salviae Miltiorrhizae 17.64~26.46g, Fructus Lycii 11.76~17.64g, Herb Gynostemmae Pentaphylli 11.76~17.64g, Fructus Ligustri Lucidi 11.76~17.64g, Rhizoma Alismatis 17.64~26.46g, Tremella 11.76~7.64g.
The prescription of blood fat reducing liver-benefiting capsules of the present invention is formed foundation: theory of Chinese medical science thinks that fatty liver is that dampness-heat of the liver pents up, and the suffocating of liver and gall imbalance causes in the phlegm-damp gives birth to qi depression to blood stasis; Stasis of blood heat-transformation of a specified duration causes taste, and expectorant heat is stopped up Sheng: injure one's stomach and kidney for a long time, cause hepatic and renal YIN deficiency.Alcoholic liver injury is to accumulate in the damp and hot alcoholism to cause liver and lose bar and reach, dysfunction of the spleen in transportation, and phlegm-damp stasis of blood knot hinders in the liver network and forms.Should use depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling, invigorating qi and benefiting blood, the method for dissipating phlegm and resolving masses.
The present invention carries out prescription according to the above-mentioned Chinese medical discrimination rule of treatment, is made up of Ganoderma, Radix Salviae Miltiorrhizae, Fructus Lycii, Herb Gynostemmae Pentaphylli, Fructus Ligustri Lucidi, Rhizoma Alismatis, Tremella etc., has the health care of blood lipid regulation, protection chemical liver injury.The present invention is according to the theory of Chinese medicine and pharmacy, and with Ganoderma, Radix Salviae Miltiorrhizae benefiting QI for activating blood circulation, transferring the fat hepatoprotective is monarch drug, the Shennong's Herbal meaning: " clothes are made light of one's life by commiting suicide and prolonged life for a long time for Ganoderma, QI invigorating tonifying liver ".Radix Salviae Miltiorrhizae " is controlled blood and is nourished blood, fall and promoting the circulation of blood ".Modern pharmacological research proves that Ganoderma, Radix Salviae Miltiorrhizae all have the effect of blood lipid regulation preferably, can alleviate the liver tissue injury that carbon tetrachloride causes, promotes liver cell regeneration.Fructus Lycii, the Fructus Ligustri Lucidi nourishing the liver and kidney that all can nourish blood, two medicine principal drug assistances are to be ministerial drug with the merit of the tonifying liver of strengthening nourishing blood, modern study shows, the Fructus Lycii master contains lycium barbarum polysaccharide, and Fructus Ligustri Lucidi contains effective ingredient such as oleanolic acid, Palmic acid, and pharmacological action such as blood fat reducing, hepatoprotective is preferably all arranged.
The Rhizoma Alismatis eliminating dampness and diuresis; the Herb Gynostemmae Pentaphylli invigorating the spleen and benefiting QI, detoxification and promoting urination, the nourishing the liver of Tremella YIN nourishing; eutrophy again; three medicines are for assistant makes it product, and modern pharmacological research shows that Rhizoma Alismatis, Herb Gynostemmae Pentaphylli, Tremella be the energy blood lipid regulation all; blood viscosity lowering; the double detoxification ability that can improve liver can alleviate the damage of chemicals to hepatic tissue, the liver protecting function.All medicines share, and full side can blood lipid regulation, and the health-care effect of protection chemical liver injury is arranged again.
Ganoderma, nature and flavor are sweet flat, go into the Liver and kidney warp, function QI invigorating tonify deficiency, nourishing the liver is calmed the nerves, and Fructus Alpiniae Oxyphyllae is intelligent.Its main component contains triterpenes and ganoderan.Modern pharmacological research proves that this product has blood pressure lowering, blood fat reducing, protects the liver and improve pharmacological actions such as memory, enhancing immunity.
Radix Salviae Miltiorrhizae, the nature and flavor hardship is slightly cold, and goes into the conscience warp, function blood circulation promoting and blood stasis dispelling, clearing away heart-fire for tranquillization.Its main component contains TANSHINONES, danshensu etc.Modern pharmacological research proves that this product can alleviate the liver tissue injury that carbon tetrachloride causes, promotes liver cell regeneration, effects such as cholesterol reducing.
Fructus Lycii, nature and flavor are sweet flat, go into the Liver and kidney warp, the function invigorating the liver and kidney of nourishing blood, lung moistening makes eye bright.Main component contains trace element such as betanin, polysaccharide and calcium, zinc.Modern pharmacological research proves that this product extractum has blood sugar lowering, blood lipid regulation effect, and lycium barbarum polysaccharide has hepatoprotective effect.
Fructus Ligustri Lucidi, the Liver and kidney warp is gone in the cold of nature and flavor sweetness and bitterness, the function invigorating the liver and kidney, crow must make eye bright.Main component contains oleanolic acid, mannitol, glucose, Palmic acid, stearic acid, oleic acid, glyceric acid etc.Modern pharmacological research proves that this product has pharmacological actions such as blood fat reducing, blood glucose, hepatoprotective.
Rhizoma Alismatis, the property slightly sweet flavor is cold, returns kidney channel, and the function promoting diuresis to eliminate damp pathogen expels the heat-evil.Main component contains alisol and daucosterol etc.Modern pharmacological research proves that this product has pharmacological actions such as blood fat reducing, cholesterol reducing, anti-fatty liver, fat-reducing.
Tremella, nature and flavor are sweet flat, the nourishing the liver of function YIN nourishing, the lung moistening and production of body fluid promoting, main component contains tremella polysaccharide etc.Modern pharmacological research proves that this product energy blood lipid regulation promotes hepatocellular metabolism, improves pharmacological actions such as liver detoxification ability.
Herb Gynostemmae Pentaphylli, nature and flavor are sweet flat, go into spleen channel, the function invigorating the spleen and benefiting QI.Main component contains saponin, flavonoid and aminoacid etc.Modern pharmacological research proves that this product has pharmacological actions such as defying age, antioxidation, blood lipid regulation, hepatoprotective, anti-fatty liver, anti-hepatic fibrosis.
Recipe ingredient of the present invention, its dosage is to be foundation with tradition each component modern pharmacology and clinical research in proved recipe and prescription, and the consumption of reference treatment senile disease and defying age body-building again is by repeatedly prescription test, overall merit and decide the dosage of active component as shown in table 1 below.
The consumption reference value of active component and the dosage of Comprehensive Assessment in table 1. prescription
Obviously, active component dosage is purpose with the health body-building all in the prescription, is starkly lower than the Drug therapy consumption.
Another problem of the present invention solves like this, a kind of preparation blood fat reducing liver-benefiting capsules method is provided, comprise extraction filtration, vacuum concentration, spray drying, the particulate preparation and dry, encapsulated and packing, control of product quality processing step of preparation raw material, medical material, it is characterized in that: (1) preparation raw material: by Ganoderma 17.64~26.46g, Radix Salviae Miltiorrhizae 17.64~26.46g, Fructus Lycii 11.76~17.64g, Herb Gynostemmae Pentaphylli 11.76~17.64g, Fructus Ligustri Lucidi 11.76~17.64g, Rhizoma Alismatis 17.64~26.46g, conduct preparation raw material after the prescription weighing of Tremella 11.76~7.64g; (2) extraction of medical material, filtration: get formula ratio and (separately Ganoderma is added 8 times of water gaging Asias boil dynamic extraction three times, each 1.5 hours, merge and filter, concentrate the back spray drying, Radix Salviae Miltiorrhizae adds 8 times of water gaging Asias boil dynamic extraction three times, each 1 hour, merge and filter, concentrate the back spray drying, then with Ganoderma, Radix Salviae Miltiorrhizae xeraphium and other Chinese medical concrete powder mixings) medical material, put in the multi-function extractor, add the about 30min of water logging bubble of 8 times of medical material amounts, boil dynamic extraction 3 times of employing Asia, each each 1.5 hours, micropore fine filtration is collected filtrate, puts in the clean container and preserves; (3) vacuum concentration: get above-mentioned filtrate, putting and being concentrated into relative density in the vacuum concentrator is 1.05-1.10 (60 ℃ heat survey), and concentrated solution is put in the clean container and preserved, the vacuum concentration process parameter: vacuum is 0.04Mpa, temperature<80 ℃; (4) spray drying: get vacuum concentration liquid, adopt the G-15 spray drying, make material obtain drying in moment, dry extract is put in the clean container and is preserved, drying parameter: 180 ℃ of intake air temperatures, 60 ℃ of air outlet temperature, 4 seconds drying times; (5) particulate preparation is with dry: get above-mentioned Chinese crude drug extract dry extract, add carboxymethyl starch sodium, starch, dextrin etc., with 95% ethanol is that wetting agent is made 40 purpose wet granulars, in 60 ℃ of heated-air circulation ovens, dry, dried granule granulate adds an amount of Pulvis Talci, puts in the clean container and preserves, the drying process parameter: baking temperature is 60 ℃, and the time is 30 minutes; (6) encapsulated and packing: relative humidity less than 58% operation workshop condition under, filled capsules is sub-packed in (100/bottle) in the hard system plastic bottle; (7) control of product quality: adopt high-efficient liquid phase chromatogram technology, its effective component is monitored quantitative analysis, be about 2.1mg/g, guaranteed the reliability and stability of product quality as content of Danshensu.
Acute toxicity test is carried out in blood fat reducing liver-benefiting capsules sampling of the present invention, and sample is to acute oral LD female, white mice great and mighty or powerful
50All,, belong to nontoxic level material with acute toxicity median lethal dose(LD 50) toxicity grading greater than the 10000mg/kg body weight.
Blood fat reducing liver-benefiting capsules of the present invention, human body recommended dose are 2.25g/60kg every day, experimentize, and establish basic, normal, high three dosage groups, are equivalent to 5 times, 10 times and 30 times of human body recommended dose respectively.Specify the functional evaluation experiment of inspection body to show through country; per os gave animal sample after 30 days; promptly have blood fat reducing and liver-protective effect; serum cholesterol (TC) and serum levels of triglyceride (TG) that sample can suppress the high nutrient fodder rat of high fat raise; can obviously reduce carbon tetrachloride poisoning mice serum glutamate pyruvate transaminase GPT, glutamic oxaloacetic transaminase, GOT GOT, hepatic lesions obviously alleviates.The health care evaluation conclusion is the health care with the liver protecting and blood fat reducing, and suitable health care is taken good care of food and taken for a long time, is a kind of novel pure natural health-care.
Advantage of the present invention: the effective ingredient Ganoderma in the blood fat reducing liver-benefiting capsules formula for a product of the present invention, Radix Salviae Miltiorrhizae, Herb Gynostemmae Pentaphylli etc. all have the effect that improves liver SOD content and vigor.These components can realize the combination of hepatoprotective and two kinds of health cares of blood lipid regulation as a Chinese medicine compound, rather than only are to realize a function by several components wherein, and several components realize another function in addition.This existing product on market is unique.
Preparation method of the present invention combines the Asia multiple advanced technologies such as dynamic extraction, micropore fine filtration, spray drying of boiling, and compares with the traditional preparation process method, innovation is all arranged and improves.Adopt the Asia dynamic extraction technology of boiling, the static extract phase ratio with traditional not only makes extractive technique be further enhanced, and all improves significantly at aspects such as energy-saving and environmental protection, labor intensity and extraction time and efficient.The microporous filter technology that adopts, wherein the microporous pipe of Cai Yonging meets hygienic requirements, and use can be washed repeatedly according to wanting filtering particle size to select in the aperture, and occupation area of equipment is little.Spray drying technology makes material obtain drying in moment, reduced the loss of polysaccharide active component, volatile ingredient, and the quality of product is improved.Adopt high-efficient liquid phase chromatogram technology, its effective component is monitored quantitative analysis, be about 2.1mg/g, guaranteed the reliability and stability of product quality as content of Danshensu.
The specific embodiment
Embodiment 1
The experiment of blood fat reducing liver-benefiting capsules blood lipid regulation of the present invention effect
1. material
Sample and processing: sample is the product content thing, and brown ceramic powder during experiment, is mixed with each dosage with distilled water, and mixing is for examination.
Laboratory animal and testing conditions: laboratory animal, cleaning level SD male rat.Sense environmental conditions, 20~24 ℃ of temperature, relative humidity 40~65%.
High lipid food: 90.5% normal feedstuff, 2% cholesterol, 0.5% cholate, 7% Adeps Sus domestica.
2. method and result
The dosage design: three dosage groups and a high fat matched group are established in experiment.Basic, normal, high three dosage groups are respectively 0.19,0.38,1.13g/kg, are equivalent to 5 times, 10 times of people's recommended dose and 30 times (people's recommended amounts is 2.25g/ day) respectively.
Experimental technique: the rat feeding normal feedstuff is observed a week under experimental situation, gets tail blood, surveys the normal value of TC observation index.After the formal experiment beginning, each treated animal is got tail blood with high lipid food two weeks of feed, measures blood fat to determine whether to form hyperlipemia.After hyperlipemia model is set up, according to the TC level, carry out random packet again, per os is irritated stomach and is given sample, irritating the stomach amount is 1ml/100g, by a definite date two to around, high fat matched group is given the distilled water with volume, continues to give high lipid food, and regularly weigh in, in experiment beginning second to around, get tail blood, measure the every index of blood fat.
Interpretation of result: variance analysis.
The result
In conventional feed one week of normal feedstuff, recording the Serum TC normal value is 1.74 ± 0.25mmol/L.The feed high lipid food is after two weeks, and recording the Serum TC value is 3.69 ± 0.68mmol/L, with normal value have the highly significant difference (t=-19.014, p=1.89E-34), the experimental hyperlipemia in rats modelling.
After the hyperlipidemia rats modelling, observation the results are shown in Table 2 to the influence of sample to the hyperlipemia rat body weight, compares with last high, medium and low three the dosage group rat body weights of test and weight gain and high fat matched group before the test, the equal not statistically significant of difference (variance analysis, P>0.05)
Table 2. sample is to the influence of hyperlipemia rat body weight
Group | Number of animals (only) | Body weight (g) (X ± SD) | Weightening finish (g) (X ± SD) |
Before the test | The test end |
High fat contrast 0.19g/kg 0.38g/kg 1.13g/kg | 10 10 10 10 | 324.2±20.1 327.4±9.2 324.1±14.8 321.0±17.5 | 365.7±16.4 367.1±12.1 360.7±18.3 359.1±13.8 | 41.5±21.8 39.7±17.1 36.6±19.0 38.1±19.3 |
F P | | 0.270 0.846 | 0.627 0.602 | 0.111 0.953 |
After the experimental hyperlipemia in rats modelling, continue to give high lipid food, when testing second week of beginning, measure serum TC, the results are shown in Table 3, compare with high fat matched group, high, medium and low three dosage groups all can obviously reduce hyperlipidemia rats serum TC content, difference has significance, (q check, P<0.05).
Table 3. sample is to the influence of hyperlipemia rat serum TC
Group | Number of animals (only) | TC(mmol/L)(X±SD) |
Before the test | The test end |
High fat contrast 0.19g/kg 0.38g/kg 1.13g/kg | 10 10 10 10 | 3.76±0.63 3.76±0.57 3.76±0.56 3.76±0.57 | 4.10±0.69 3.55±0.61
* 2.89±0.54
* 2.68±0.52
* |
F P | | 4.65E-05 1.000 | 11.918 1.44E-05 |
Q check: compare * P<0.05 with high fat matched group
After the experimental hyperlipemia in rats modelling, continue to give high lipid food, when testing second week of beginning, measure serum TG, the results are shown in Table 4, compare with high fat matched group, high, medium and low three dosage groups all can obviously reduce hyperlipidemia rats serum TG content, difference has significance, (q check, P<0.05).
Table 4. sample is to the influence of hyperlipemia rat serum TG
Group | Number of animals (only) | TG(mmol/L)(X±SD) |
Before the test | The test end |
High fat contrast 0.19g/kg 0.38g/kg 1.13g/kg | 10 10 10 10 | 1.64±0.23 1.60±0.23 1.66±0.24 1.61±0.29 | 1.68±0.18 1.21±0.41
* 1.22±0.26
* 1.09±0.24
* |
F P | | 0.122 0.946 | 8.314 0.0002 |
Q check: compare * P<0.05 with high fat matched group
After the experimental hyperlipemia in rats modelling, continue to give high lipid food, in second week of experiment beginning, measure Serum HDL-C, the results are shown in Table 5, each dosage group rat blood serum HDL-C value and high fat control rats are relatively, the difference not statistically significant, (variance analysis, P>0.05).
Table 5. sample is to the influence of hyperlipemia rat Serum HDL-C
Group | Number of animals (only) | HDL-C(mg/dL)(X±SD) |
Before the test | The test end |
High fat contrast | 10 | 60.39±13.92 | 73.09±12.83 |
0.19g/kg 038g/kg 1.13g/kg |
10 10 10 |
63.82±11.28 58.80±11.79 63.51±12.04 |
84.21±20.66 69.34±19.24 70.81±12.06 |
F P |
|
0.394 0.758 |
1.643 0.197 |
This experimental result shows: compare with high fat control rats, high, medium and low dosage group all can obviously reduce hyperlipidemia rats serum cholesterol (TC) and serum levels of triglyceride (TG) content.
Conclusion: the present invention has the blood lipid regulation effect.
Embodiment 2
Blood fat reducing liver-benefiting capsules of the present invention is to the auxiliary protection function experiment of chemical liver injury
The sample character: sample contents is a brown granular.
The dosage design: sample human body recommended dose is 2.25g/60kg every day.This experiment is established basic, normal, high three.
0.19,0.38,1.13g/kg the dosage group:, other establishes liver injury model group and normal control group (giving distilled water).
Sample treatment: sample thief 0.19,0.38,1.13g adding distil water respectively make into even suspension to 20ml, are the test liquid of high, medium and low three dosage groups.
Laboratory animal: Kunming kind white mice, the 20-22 gram, female.
Give sample loading mode: irritate stomach, irritating the stomach volume is 0.4ml/20g.
Experimental technique and result:
Each dosage group is given sample, and matched group and model group are drunk distilled water, continuous 30 days.The 30th day each dosage group and model group CCL
4Contamination, dosage 24mg/kg, lumbar injection (i.p).The 31st day, 5 treated animals are plucked eyeball and got blood, and were centrifugal, get serum.Measure following biochemical indicator: serum glutamic pyruvic transminase (GPT), glutamic oxaloacetic transaminase, GOT (GOT), white/globulin ratio (A/G); And get liver and carry out histopathologic examination.Experimental result Spss software statistics.
1. body weight sees Table 6
Table 6. sample is to the influence of the weight of animals
Group | Number of animals | Initial body weight | Mid-term body weight | Final body weight |
Normal control CCL
4Dosage high dose in the model low dosage
| 10 10 10 10 10 | 19±0.9 19±0.8 19±.0.9 19±0.8 19±0.9 | 27±1.7 28±1.7 27±1.2 27±1.7 28±1.4 | 37±1.5 37±1.0 34±2.3 36±3.8 36±2.3 |
By table 6 as seen, each dosage group and CCL of sample
4Model group is compared, difference that there are no significant.
2. biochemistry detection the results are shown in Table 7
Table 7. biochemistry detection result
Group | Number of animals (only) | Glutamate pyruvate transaminase (IU/L) | Glutamic oxaloacetic transaminase, GOT (IU/L) | In vain/the globulin ratio |
Normal control CCL
4Dosage high dose in the model low dosage
| 10 10 10 10 10 | 62±11
* 831±133 826±162 486±104
* 383±67
* | 88±8
* 953±263 732±234 464±100
* 168±25
* | 1.77±0.52 1.92±0.50 1.82±0.52 2.02±0.85 1.85±0.53 |
* P<0.05 and CCL
4Model group compares, (through variance analysis)
By table 7 as seen, the glutamate pyruvate transaminase of normal control group, glutamic oxaloacetic transaminase, GOT content are starkly lower than CCL
4There is significant difference in model group, and the model establishment is described.The glutamic oxaloacetic transaminase, GOT of the middle and high dosage group of sample, glutamate pyruvate transaminase all obviously reduce, with CCL
4Relatively all there is significant difference in model group.
3. pathological examination results sees Table 8
Table 8. pathologic finding total mark
Group | Number of animals | Granular degeneration | Hydropic degeneration | The balloon degeneration | Steatosis | The endochylema cohesion | Necrocytosis | Inflammatory cell infiltration | Total points | Average mark |
Contrast CCL
4Dosage high dose in the model low dosage
|
10 10 10 10 10 |
15 12 12 13 14 |
12 16 12 12 11 |
0 14 10 9 7 |
0 10 8 7 4 |
0 34 26 24 24 |
0 34 27 24 24 |
2 14 13 11 10 |
29 134 108 100 94 |
2.9±0.9
* 13.4±3.1 10.8±2.3 10.0±3.0 9.4±2.6
* |
* P<0.05 and CCL
4Model group is (through variance analysis) relatively
As shown in table 8, by check substantially and the microscopy result as seen, the pathology integration of normal control group is starkly lower than CCL
4There is significant difference in model group, and the model establishment is described.Sample high dose group and CCL
4Model control group is compared, and the pathology integration obviously descends, and has significant difference.
This experiment conclusion: the animal per os gave sample of the present invention after 30 days, had the protective effect to hepatic injury due to the chemicals.
Embodiment 3
The preparation method of blood fat reducing liver-benefiting capsules of the present invention, comprise extraction filtration, vacuum concentration, spray drying, the particulate preparation and dry, encapsulated and packing, control of product quality processing step of preparation raw material, medical material, it is characterized in that, (1) preparation raw material: by Ganoderma 17.64g, Radix Salviae Miltiorrhizae 17.64g, Fructus Lycii 11.766g, Herb Gynostemmae Pentaphylli 11.76g, Fructus Ligustri Lucidi 11.76g, Rhizoma Alismatis 17.64g, conduct preparation raw material after the prescription weighing of Tremella 11.80g; (2) extraction of medical material, filtration: get formula ratio and (separately Ganoderma is added 8 times of water gaging Asias boil dynamic extraction three times, each 1.5 hours, merge and filter, concentrate the back spray drying, Radix Salviae Miltiorrhizae adds 8 times of water gaging Asias boil dynamic extraction three times, each 1 hour, merge and filter, concentrate the back spray drying, then with Ganoderma, Radix Salviae Miltiorrhizae xeraphium and other Chinese medical concrete powder mixings) medical material, put in the multi-function extractor, add the about 30min of water logging bubble of 8 times of medical material amounts, boil dynamic extraction 3 times of employing Asia, each each 1.5 hours, micropore fine filtration is collected filtrate, puts in the clean container and preserves; (3) vacuum concentration: get above-mentioned filtrate, put and be concentrated into relative density in the vacuum concentrator and be 1.05~1.10 (60 ℃ of heat are surveyed), concentrated solution is put in the clean container and preserved, the vacuum concentration process parameter: vacuum is 0.04Mpa, temperature<80 ℃; (4) spray drying: get vacuum concentration liquid, adopt the G-15 spray drying, make material obtain drying in moment, dry extract is put in the clean container and is preserved, drying parameter: 180 ℃ of intake air temperatures, 60 ℃ of air outlet temperature, 4 seconds drying times; (5) particulate preparation is with dry: get above-mentioned Chinese crude drug extract dry extract, add carboxymethyl starch sodium, starch, dextrin etc., with 95% ethanol is that wetting agent is made 40 purpose wet granulars, in 60 ℃ of heated-air circulation ovens, dry, dried granule granulate adds an amount of Pulvis Talci, puts in the clean container and preserves, the drying process parameter: baking temperature is 60 ℃, and the time is 30 minutes; (6) encapsulated and packing: relative humidity less than 58% operation workshop condition under, filled capsules is sub-packed in (100/bottle) in the hard system plastic bottle; (7) control of product quality: adopt high-efficient liquid phase chromatogram technology, its effective component is monitored, quantitative analysis is about 2.1mg/g as content of Danshensu, has guaranteed the reliability and stability of product quality.
Instructions about how to take medicine: obey every day 3 times, each 2, (the human body recommended dose is 2.25g/60kg, day).